wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
MCO.2017.1320
MCO.2017.1320
http://dx.doi.org/10.3892/MCO.2017.1320
Progression-free survival of first-line treatment with molecular-targeted therapy may be a meaningful intermediate endpoint for overall survival in patients with metastatic renal cell carcinoma.
P356
Q41145898-52DDA884-1F39-48B5-9365-F46279816976
P356
MCO.2017.1320
http://dx.doi.org/10.3892/MCO.2017.1320